Hybio Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year of 2015; Announces Management Changes
The company also approved the resignation of Yu Xiufeng as independent director, and elected Cao Dieyun as independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.41 CNY | +0.71% |
|
-3.14% | -15.98% |
05-29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
05-29 | Hybio Pharmaceutical Grants Commercial Rights of Weight Loss Drug to Sansheng Mandi Pharmaceutical | MT |
1st Jan change | Capi. | |
---|---|---|
-15.98% | 1.39B | |
+19.89% | 43.67B | |
+26.21% | 22.79B | |
+20.44% | 15.45B | |
+17.82% | 14.29B | |
+53.26% | 12.83B | |
-0.05% | 6.79B | |
-11.88% | 6.52B | |
+12.62% | 5.59B | |
-8.87% | 5.73B |